Preferred Label : Recombinant Human Papillomavirus Nonavalent Vaccine;
NCIt synonyms : Recombinant HPV Nonavalent Vaccine; Nonavalent HPV VLP Vaccine; Recombinant Human Papillomavirus 9-valent Vaccine;
NCIt definition : A non-infectious, recombinant, nonavalent vaccine prepared from highly purified virus-like
particles (VLPs) comprised of the major capsid (L1) proteins from human papillomavirus
(HPV) types 6, 11, 16, 18, 31, 33, 45, 52, and 58, with active immunizing activity.
Upon administration, the recombinant HPV nonavalent vaccine activates the immune system
to produce antibodies against the 9 HPV types. This protects against HPV infection
and HPV-related cancers. Altogether, HPV types 6, 11, 16, 18, 31, 33, 45, 52, and
58 account for the majority of the HPV types that cause cervical, vulvar, vaginal
and anal cancers.;
Drug name : Gardasil 9;
Origin ID : C119664;
UMLS CUI : C3897122;
Currated CISMeF NLP mapping
- Semantic type(s)
- UMLS correspondences (same concept)
- concept_is_in_subset
- has_target
